All News #Library
Rare Diseases
Neurocrine expands into metabolic diseases with $2.9 billion Sole
06 Apr 2026 //
REUTERS
Neurocrine Uses PicnicHealth to Identify Gaps in Rare Conditions
15 Jul 2025 //
PR NEWSWIRE
Neurocrine: Crenessit™ Data in Classic CAH Patients
15 May 2025 //
PR NEWSWIRE
Neurocrine`s Crinecerfont Set To Transform CAH Market
30 Sep 2024 //
PR NEWSWIRE
Neurocrine launches CAH rare disease education campaign ahead of FDA submission
24 Apr 2024 //
ENDPTS

Market Place
Sourcing Support